Raglan Capital: Creating in-house companies that can be rapidly listed on the stock exchange.

Raglan Capital and its principals has had a long successful history of providing corporate finance and investment banking services to a range of Irish and international companies. And in the last number of years, Raglan ceased providing any third party corporate finance services and is now solely focused upon creating our own companies in-house that can be rapidly listed on the London stock exchange. Our general target is to complete an IPO within two years post inception of the company.

In 2016, Raglan established Amryt Pharma Plc which is now listed on both the London and Dublin Stock Exchanges. Amryt has a market capitalisation in excess of £50m and is now an established European orphan drug company. The company already has rapidly growing monthly sales revenues while at the same time managing a pipeline of drugs in development including its potential blockbuster EB orphan drug, which is now in its final FDA phase three trials. Following on from the success Amryt Pharma, Raglan established a second orphan focused company in mid-2017 called Open Orphan. Open Orphan is a European & Middle East Focused Orphan Drug, Rare Disease and Specialty Pharma Platform. Open Orphan is led by an experienced Board and management team with expertise in orphan drug regulatory approval, market access and reimbursement, commercialisation and launch optimisation. Open Orphan is due to IPO on both the London and Dublin Stock Exchange in early 2019.

Raglan has also been very active in the Oil & Gas sector for many years and as such, we hold in-depth knowledge of the industry having completed a variety of related projects. T5 Oil & Gas, which is another in-house Raglan creation, is due to complete its IPO mid-2018. Prior to that, Raglan established Fastnet Oil & Gas plc which floated on the London and Dublin stock exchanges raising over $50m.

The team behind Raglan Capital have many years of deal making experience with a proven track record of achieving exceptional results.

With offices in Dublin, London and Vienna, our relationships include regular contact with the Dublin and international stock brokers, investment banks, private equity firms and a broad range of investors which provides Raglan Capital with invaluable access to local advisers and contacts when completing international transactions.